Triclabendazole: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Triclabendazole. Educational only — not medical advice.
Labeled uses
EGATEN® is indicated for the treatment of fascioliasis in patients 6 years of age and older.
Source: FDA labeling via NIH DailyMed (set 5552884e…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.